Study of the Safety and Leukostimulatory Activity of the Preparation "Panagen" in Patients With Breast Cancer
Phase 2
Completed
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2014-04-16
- Last Posted Date
- 2014-07-15
- Lead Sponsor
- Panagen, Limited Liability Company
- Target Recruit Count
- 80
- Registration Number
- NCT02115984
© Copyright 2025. All Rights Reserved by MedPath